作者: Edward D. Gomperts , Raffaello de Biasi , René De Vreker
DOI: 10.1016/S0887-7963(92)70155-2
关键词:
摘要: All reported studies to date, whether comparative or not, have shown a tendency toward slower decrease in CD4+ numbers patients receiving very high-purity agents with the rapidity fall-off being affected by level of (low decreasing more rapidly), age (older persons showing rapid cell fall-off), and anti-HIV therapy. Clearly, these observations need be extended numbers, should also similarly compared therapies.